The Association of American Medical Colleges (AAMC) and the Council on Governmental Relations (COGR) submitted joint comments to the DEA in support of the proposed...
Cannabis/Controlled Substances
Regulatory requirements associated with clinical and non-clinical research on Schedule I and II Controlled Substances (including cannabis) and issues arising from differences between state and federal laws governing cannabis research.
Featured
COGR Submits Response to Congressional RFI on Federal Regulation of CBD Products
COGR submitted comments in response to a federal Request for Information regarding cannabidiol (CBD). COGR’s letter emphasizes the importance of continued research...
COGR Responds to HHS Notice of Proposed Rulemaking “Confidentiality of Substance Abuse Disorder Patient Records”
COGR, representing over 200 U.S. research institutions, submitted comments on the Department of Health and Human Services' proposed rule to align the confidentiality...
Resources
Point of Contact
Kristin West
Director, Research Ethics & Compliance
All Cannabis/Controlled Substances Articles
Challenges Relating to the 2018 Farm Bill: June 2019 Meeting
The document summarizes concerns and challenges faced by research universities regarding changes introduced by the 2018 Farm Bill (Agriculture Improvement Act of 2018) and corresponding agency guidance, particularly in the administration of federally funded agricultural research, education, and extension grants. Key issues include the introduction of a matching requirement for certain programs, re
